<DOC>
	<DOCNO>NCT02050854</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics aripiprazole subject Bipolar 1 Disorder Schizophrenia history suboptimal aderence currently treatment oral aripiprazole .</brief_summary>
	<brief_title>Open-Label Observational Pilot Study Evaluate Pharmacokinetics Aripiprazole Subjects With Bipolar 1 Disorder Schizophrenia</brief_title>
	<detailed_description>The purpose study evaluate pharmacokinetics aripiprazole subject Bipolar 1 Disorder Schizophrenia history suboptimal aderence currently treatment oral aripiprazole . This open-label observational pilot trial compare PK profile aripiprazole Visit 1 subject receive oral aripiprazole potential suboptimal adherent behavior assign medication . Information obtain current trial use inform conduct randomize , open-label , parallel-group trial assess between-group change baseline adherence use PK sample subject receive oral aripiprazole without MIND1 System ( Protocol 316-13-211 ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Male female subject 18 55 year age ( inclusive ) time inform consent Subjects primary current Axis 1 disorder bipolar 1 disorder schizophrenia define DSMIVTR criterion , treat outpatient set least 2 month screen Subjects score 17 Morisky 8Item Medication Adherence Scale ( MMAS8 ) Subjects bipolar 1 disorder YMRS score 10 25 ( inclusive ) , subject schizophrenia PANSS score 60 90 ( inclusive ) Subjects able ingest oral medication Subjects currently prescribe oral aripiprazole either bipolar 1 disorder schizophrenia , change Aripiprazole regimen dose last 2 week Subjects exacerbation mood psychotic symptom receive treatment noncompliant treatment bipolar 1 disorder schizophrenia For subject enrol bipolar 1 disorder , current bipolar episode mixed manic ( current must depressive episode ) Subjects current Axis I ( DSMIVTR ) diagnosis bipolar 1 disorder schizophrenia Subjects current Axis II ( DSMIVTR ) diagnosis Subjects able selfadminister medication Subjects reside attend facility medication administer Subjects score 0 8 Morisky 8Item Medication Adherence Scale ( MMAS8 ) Subjects currently meet DSMIVTR criterion substance dependence Subjects history inpatient hospitalization psychiatric reason within past 2 month screen Subjects receive investigational product within last 30 day Subjects know allergic , intolerant , unresponsive prior treatment Aripiprazole quinolinones Subjects , per investigator 's judgment , acutely psychotic manic and/or exhibit symptom currently require hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Treatment Adherence</keyword>
</DOC>